PCV67 BUDGET IMPACT OF RIVAROXABAN 2.5 MG IN COMBINATION WITH ASPIRIN IN TREATMENT OF PATIENTS WITH CORONARY ARTERY DISEASE (CAD) OR PERIPHERAL ARTERY DISEASE (PAD) IN GREECE
HomePublicationsPCV67 BUDGET IMPACT OF RIVAROXABAN 2.5 MG IN COMBINATION WITH ASPIRIN IN TREATMENT OF PATIENTS WITH CORONARY ARTERY DISEASE (CAD) OR PERIPHERAL ARTERY DISEASE (PAD) IN GREECE
PCV67 BUDGET IMPACT OF RIVAROXABAN 2.5 MG IN COMBINATION WITH ASPIRIN IN TREATMENT OF PATIENTS WITH CORONARY ARTERY DISEASE (CAD) OR PERIPHERAL ARTERY DISEASE (PAD) IN GREECE
2019 Value in Health
Kalogeropoulou, M. | Gkouvitsos, I. | Barlogiannis, T. | Bowrin, K. | Briere, J.B. | Millier, A. | Karabis, A. |
Volume: 22,
Issue: ,
Pages: S553,
